Avijit Lahiri
Avijit Lahiri is a researcher in cardiology[1] in the UK.[2]
Career[edit]
He graduated from the Calcutta National Medical College, then affiliated with the University of Calcutta in India. He completed his internship and training at the Northwick Park Hospital, in London. He was a consultant cardiologist and director of cardiac research Institute of Medical Research in Northwick Park Hospital and St. Marks, Imperial College London for over 20 years.
Lahiri is the Director of the Cardiac Imaging and Research Department in Wellington Hospital, London.[3][4][5][6]
Lahiri's research interests are mainly in diagnostic imaging[7][8] and therapeutics in cardiovascular medicine. He was previously Director of Cardiovascular Research at Northwick Park Hospital, where he performed clinical therapeutic trials, and developed cardiac imaging protocols and techniques.[9]
Research and trials[edit]
He has published over 270 peer-reviewed scientific publications[10][11][12] [13] [14] 16 book chapters and has presented over 290 invited lectures.[15]
He has contributed[16] to a number of clinical trials, including the first trials of Carvedilol, in heart failure and acute myocardial infarction; the first clinical trial of 7E3 (and its chimeric form), in patients with coronary artery disease; the first clinical trial of Ranolazine in stable angina. He also developed TC-99m tetrofosmin (Myoview) for myocardial perfusion imaging in man in conjunction with Amersham International (now GE).[17]
Founder/Co-President- International Congress of Nuclear Cardiology (ICNC), 1993
Introduced Cardiac CT imaging (Coronary Artery Calcium Scanning) in the UK. Contributed in early diagnostic imaging in asymptomatic diabetes. Referenced in the guidelines of imaging in diabetes- American Heart Association,/American College of Cardiology, European Society of Cardiology and NICE Guidelines.
Awards and recognition[edit]
- Honorary member, Royal College of Physicians[18]
- The Howard Gilman Foundation Distinguished Visiting Scholar of Cornell University Medical School[19]
- C Merit awarded by Northwick Park and St. Mark's Hospital[20]
- Director, British Cardiac Research Trust, UK
- The honorary International Professor, Apollo Hospitals Group, India
References[edit]
- ^ Soman, Prem; Taillefer, Raymond; Depuey, E.Gordon; Udelson, James E; Lahiri, Avijit (2001). "Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease". Journal of the American College of Cardiology. 37 (2): 458–62. doi:10.1016/S0735-1097(00)01148-7. PMID 11216963.
- ^ "Advisory Team". Archived from the original on 17 May 2011. Retrieved 25 February 2010.
- ^ [1] Archived 17 July 2011 at the Wayback Machine
- ^ "Eminent British Cardiologist, Pioneer in Nuclear Cardiology, Dr. Avijit Lahiri, Wellington Hospital, London, UK, Europe". Britishcardiacresearch.org. Archived from the original on 7 October 2015. Retrieved 10 December 2014.
- ^ [2] [dead link]
- ^ Akram, Yasmin (18 August 2007). "Nuclear cardiology". Career Focus. BMJ. 335 (7615): s61. doi:10.1136/bmj.335.7615.s61. S2CID 220090876.
- ^ "Heart Scan News". Archived from the original on 26 January 2010. Retrieved 25 February 2010.
- ^ "Latest News - AandD Medical UK". Aandd-eu.net. Archived from the original on 20 February 2012. Retrieved 10 December 2014.
- ^ Kelion, A; Davies, G; Flint, J; Harbinson, M; Hilson, A; Lahiri, A; Lim, E; Prvulovich, L; Sabharwal, N; Tweddel, A; Underwood, R; Woldman, S; Jones, I; Latus, K; McKenna, C; Parkin, V; Powell, S; Boyle, R; British Cardiac Society, the British Nuclear Cardiology Society (2005). "Setting up a myocardial perfusion scintigraphy service: Clinical and business aspects". Nuclear Medicine Communications. 26 (10): 849–60. doi:10.1097/00006231-200510000-00002. PMID 16160643.
- ^ Gatasko, Gavin I; Senior, Roxy; Lahiri, Avijit (2002). "A simple model to predict left ventricular systolic dysfunction in a multiethnic community". Journal of the American College of Cardiology. 39: 176. doi:10.1016/S0735-1097(02)80780-X.
- ^ Anand, D. V; Lahiri, A (2003). "Myocardial perfusion imaging versus biochemical markers in acute coronary syndromes". Nuclear Medicine Communications. 24 (10): 1049–54. doi:10.1097/00006231-200310000-00004. PMID 14508160. S2CID 33401171.
- ^ Sabharwal, N K (2003). "Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease". Heart. 89 (11): 1291–7. doi:10.1136/heart.89.11.1291. PMC 1767933. PMID 14594881.
- ^ Basu, S; Senior, R; Raval, U; Van Der Does, R; Bruckner, T; Lahiri, A (1997). "Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial". Circulation. 96 (1): 183–91. doi:10.1161/01.CIR.96.1.183. PMID 9236433.
- ^ "Advanced Ultrasound". Diagnosticimaging.com. Retrieved 10 December 2014.
- ^ "Short CV" (PDF). Archived from the original (PDF) on 3 March 2012. Retrieved 25 February 2010.
- ^ Gani, Firoz; Jain, Diwakar; Lahiri, Avijit (2007). "The role of cardiovascular imaging techniques in the assessment of patients with acute chest pain". Nuclear Medicine Communications. 28 (6): 441–9. doi:10.1097/MNM.0b013e3281744491. PMID 17460534. S2CID 28178061.
- ^ Anand, Dhakshinamurthy Vijay; Lahiri, Avijit; Lim, Eric; Hopkins, David; Corder, Roger (2006). "The Relationship Between Plasma Osteoprotegerin Levels and Coronary Artery Calcification in Uncomplicated Type 2 Diabetic Subjects". Journal of the American College of Cardiology. 47 (9): 1850–7. doi:10.1016/j.jacc.2005.12.054. PMID 16682312.
- ^ "Obituary: Dr. Edward Bernard Raftery died 16 July 1995". Cardiovascular Drugs and Therapy. 10 (2): 193. 1996. doi:10.1007/BF00823599. S2CID 26885122.
- ^ "Free Prescriptions, Patient Assistance Programs, Free Medicine". Themedicineprogram.com. Archived from the original on 18 July 2011. Retrieved 10 December 2014.
- ^ Galasko, Gavin IW; Barnes, Sophie C; Collinson, Paul; Lahiri, Avijit; Senior, Roxy (2006). "What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: Natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?". European Heart Journal. 27 (2): 193–200. doi:10.1093/eurheartj/ehi559. PMID 16267076.